We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Idexx (IDXX) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Read MoreHide Full Article
In its upcoming report, Idexx Laboratories (IDXX - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $3.31 per share, reflecting an increase of 35.7% compared to the same period last year. Revenues are forecasted to be $1.07 billion, representing a year-over-year increase of 6.3%.
The current level reflects an upward revision of 0.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Idexx metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts predict that the 'Revenue- Companion Animal Group (CAG)' will reach $978.21 million. The estimate points to a change of +6.1% from the year-ago quarter.
The combined assessment of analysts suggests that 'Revenue- Other' will likely reach $4.41 million. The estimate points to a change of +3.9% from the year-ago quarter.
Analysts forecast 'Revenue- Livestock and poultry diagnostics (LPD)' to reach $31.51 million. The estimate points to a change of +4% from the year-ago quarter.
The consensus among analysts is that 'Revenue- Water' will reach $50.79 million. The estimate indicates a change of +8.7% from the prior-year quarter.
The average prediction of analysts places 'Revenue- Companion Animal Group- United States' at $663.10 million. The estimate points to a change of +5.5% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenue- Companion Animal Group- International' should come in at $312.95 million. The estimate suggests a change of +6.6% year over year.
Based on the collective assessment of analysts, 'Revenue- LPD- International' should arrive at $25.76 million. The estimate indicates a year-over-year change of +2.2%.
Analysts' assessment points toward 'Revenue- Water- International' reaching $24.16 million. The estimate suggests a change of +8.5% year over year.
Analysts expect 'Gross Profit - CAG' to come in at 62.6%. Compared to the current estimate, the company reported 61.7% in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Gross Profit - Other' of 29.6%. The estimate is in contrast to the year-ago figure of 57.8%.
The consensus estimate for 'Gross Profit - LPD' stands at 51.7%. Compared to the current estimate, the company reported 51.3% in the same quarter of the previous year.
It is projected by analysts that the 'Gross Profit - Water' will reach 69.6%. The estimate compares to the year-ago value of 68.6%.
Over the past month, Idexx shares have recorded returns of +5.6% versus the Zacks S&P 500 composite's +3.4% change. Based on its Zacks Rank #3 (Hold), IDXX will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Idexx (IDXX) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
In its upcoming report, Idexx Laboratories (IDXX - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $3.31 per share, reflecting an increase of 35.7% compared to the same period last year. Revenues are forecasted to be $1.07 billion, representing a year-over-year increase of 6.3%.
The current level reflects an upward revision of 0.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Idexx metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts predict that the 'Revenue- Companion Animal Group (CAG)' will reach $978.21 million. The estimate points to a change of +6.1% from the year-ago quarter.
The combined assessment of analysts suggests that 'Revenue- Other' will likely reach $4.41 million. The estimate points to a change of +3.9% from the year-ago quarter.
Analysts forecast 'Revenue- Livestock and poultry diagnostics (LPD)' to reach $31.51 million. The estimate points to a change of +4% from the year-ago quarter.
The consensus among analysts is that 'Revenue- Water' will reach $50.79 million. The estimate indicates a change of +8.7% from the prior-year quarter.
The average prediction of analysts places 'Revenue- Companion Animal Group- United States' at $663.10 million. The estimate points to a change of +5.5% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenue- Companion Animal Group- International' should come in at $312.95 million. The estimate suggests a change of +6.6% year over year.
Based on the collective assessment of analysts, 'Revenue- LPD- International' should arrive at $25.76 million. The estimate indicates a year-over-year change of +2.2%.
Analysts' assessment points toward 'Revenue- Water- International' reaching $24.16 million. The estimate suggests a change of +8.5% year over year.
Analysts expect 'Gross Profit - CAG' to come in at 62.6%. Compared to the current estimate, the company reported 61.7% in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Gross Profit - Other' of 29.6%. The estimate is in contrast to the year-ago figure of 57.8%.
The consensus estimate for 'Gross Profit - LPD' stands at 51.7%. Compared to the current estimate, the company reported 51.3% in the same quarter of the previous year.
It is projected by analysts that the 'Gross Profit - Water' will reach 69.6%. The estimate compares to the year-ago value of 68.6%.
View all Key Company Metrics for Idexx here>>>Over the past month, Idexx shares have recorded returns of +5.6% versus the Zacks S&P 500 composite's +3.4% change. Based on its Zacks Rank #3 (Hold), IDXX will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .